FDA
-
-
-
-
-
-
-
Jasper Therapeutics (JSPR) Appoints Edwin J. Tucker as Chief Medical Officer
-
-
-
-
-
-
-
Jasper Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Jasper Therapeutics Announces Plans for Registrational Study of JSP191 in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation after Ty
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/13: (WTRH) (KOSS) (RVNC) Higher; (RGLS) (ARDX) (STIM) Lower (more...)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

